report to the Secretary of Health and Human Services and 
appropriate Federal and non-Federal agencies. 
‘‘SEC. 2902. DEMONSTRATION GRANTS TO LOWER THE RATE 
OF GESTATIONAL DIABETES AND OBESITY 
DURING PREGNANCY. 
‘‘(a) IN GENERAL.—The Secretary of Health and 
Human Services, acting through the Director of the Cen-
ters for Disease Control and Prevention, in consultation 
with the Research Advisory Committee established under 
section 2901, shall award grants, on a competitive basis, 
to eligible entities for demonstration projects that test 
specified hypotheses about interventions designed to re-
duce the incidence of gestational diabetes and obesity 
among young women and implement relevant activities. In 
making such grants, the Director shall act on scientific 
findings that— 
‘‘(1) the prevention or delay of type 2 diabetes 
is possible for older adults; 
‘‘(2) the diabetes risk status of an individual is 
likely established during the individual’s earlier age 
(adolescence through the age of 30); 
‘‘(3) women are uniquely capable of dem-
onstrating their diabetes risk status, through acquir-
ing gestational diabetes during the challenge of preg-
nancy; 
VerDate Aug 31 2005 
23:11 Sep 26, 2006
Jkt 049196
PO 00000
Frm 00007
Fmt 6652
Sfmt 6201
E:\BILLS\H6147.IH
H6147
pwalker on PRODPC60 with BILLS
‘‘(4) gestational diabetes itself is a well-estab-
lished risk factor for a woman’s subsequent transi-
tion to type 2 diabetes; and 
‘‘(5) gestational diabetes may confer risks of fu-
ture obesity and type 2 diabetes on the children of 
a mother with gestational diabetes. 
‘‘(b) APPLICATION.—An eligible entity desiring to re-
ceive a grant under this section shall submit to the Direc-
tor of the Centers for Disease Control and Prevention— 
‘‘(1) an application at such time, in such man-
ner, and containing such information as the Director 
may require; and 
‘‘(2) a plan to— 
‘‘(A) lower the rate of gestational diabetes 
and obesity during pregnancy; or 
‘‘(B) conduct post-natal methods of track-
ing women who had gestational diabetes in 
order to develop ways to lower the incidence of 
such mothers developing type 2 diabetes. 
‘‘(c) USES OF FUNDS.—An entity receiving a grant 
under this section shall use grant funds to carry out dem-
onstration projects, which may include— 
‘‘(1) expanding community-based health pro-
motion education, activities, and incentives focused 
VerDate Aug 31 2005 
23:11 Sep 26, 2006
Jkt 049196
PO 00000
Frm 00008
Fmt 6652
Sfmt 6201
E:\BILLS\H6147.IH
H6147
pwalker on PRODPC60 with BILLS
on the prevention of gestational diabetes and obesity 
during pregnancy; 
‘‘(2) aiding State-based diabetes prevention and 
control programs to collect, analyze, disseminate, 
and report surveillance data on women with, and at 
risk for, gestational diabetes and obesity during 
pregnancy; 
‘‘(3) building capacity with State-based part-
ners to implement programs and interventions based 
on surveillance data; and 
‘‘(4) training and encouraging health care pro-
viders to promote risk assessment, quality care, and 
self-management for gestational diabetes and obesity 
during pregnancy and its complications in the prac-
tice settings of the health care providers. 
‘‘(d) REPORTS.— 
‘‘(1) CDC REPORT.—Not later than 2 years 
after the date of enactment of the Gestational Dia-
betes Act of 2006, the Director of the Centers for 
Disease Control and Prevention shall prepare and 
submit a report to the Secretary of Health and 
Human Services concerning the results of the stud-
ies conducted through the grants awarded under this 
section. 
VerDate Aug 31 2005 
23:11 Sep 26, 2006
Jkt 049196
PO 00000
Frm 00009
Fmt 6652
Sfmt 6201
E:\BILLS\H6147.IH
H6147
pwalker on PRODPC60 with BILLS
‘‘(2) SECRETARY REPORT.—Not later than 90 
days after receiving the report described in para-
graph (1), the Secretary shall prepare and submit a 
report to Congress concerning the results and find-
ings of the report. 
‘‘(e) DEFINITION OF ELIGIBLE ENTITY.—In this sec-
tion, the term ‘eligible entity’ means a nonprofit organiza-
tion (such as an academic center or community health cen-
ter) or a State health agency. 
‘‘(f) AUTHORIZATION OF APPROPRIATIONS.—There 
are authorized to be appropriated to carry out this section 
$5,000,000 for fiscal year 2007 and such sums as may 
be necessary for each of the fiscal years 2008 through 
2011. 
‘‘SEC. 2903. RESEARCH EXPANSION OF GESTATIONAL DIA-
BETES AND OBESITY DURING PREGNANCY. 
‘‘(a) IN GENERAL.—The Director of the Centers for 
Disease Control and Prevention and the Director of the 
National Institute of Child Health and Human Develop-
ment, in collaboration with the National Institute of Dia-
betes and Digestive and Kidney Diseases, shall conduct 
and support basic, clinical, and public health research re-
garding gestational diabetes and obesity during preg-
nancy. Such research shall include— 
VerDate Aug 31 2005 
23:11 Sep 26, 2006
Jkt 049196
PO 00000
Frm 00010
Fmt 6652
Sfmt 6201
E:\BILLS\H6147.IH
H6147
pwalker on PRODPC60 with BILLS
‘‘(1) investigating therapies, interventions, and 
agents to detect, treat, and slow the incidence of, 
gestational diabetes and obesity during pregnancy; 
‘‘(2) developing and testing novel approaches to 
the design and analysis of clinical trials; 
‘‘(3) facilitating the enrollment of patients for 
clinical trials, including patients from diverse popu-
lations and populations who suffer disproportionately 
from these conditions; 
‘‘(4) developing improved diagnostics and 
means of patient assessment for gestational diabetes 
and obesity during pregnancy; and 
‘‘(5) conducting public health research to fur-
ther knowledge on epidemiologic, socioenvironmental, 
behavioral, translation, and biomedical factors that 
influence gestational diabetes and obesity during 
pregnancy. 
‘‘(b) AUTHORIZATION OF APPROPRIATIONS.—There 
are authorized to be appropriated to carry out this section 
$8,000,000 for fiscal year 2007 and such sums as may 
be necessary for each of the fiscal years 2008 through 
2011. 
‘‘SEC. 2904. SCREENING FOR GESTATIONAL DIABETES. 
‘‘The Director of the Centers for Disease Control and 
Prevention shall encourage screening for gestational dia-
VerDate Aug 31 2005 
23:11 Sep 26, 2006
Jkt 049196
PO 00000
Frm 00011
Fmt 6652
Sfmt 6201
E:\BILLS\H6147.IH
H6147
pwalker on PRODPC60 with BILLS